We are live on ! Find out more
CMED

CHINA MEDICAL TECHNOLOGIES, INC SPN ADR
CMED

Delisted

CMED was delisted on the 6th of February, 2012.

Back to rankings

1 hedge funds and large institutions have $256 invested in CHINA MEDICAL TECHNOLOGIES, INC SPN ADR in 2022 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding

Funds holding: 1 → 1 (0)

0% more capital invested

Capital invested by funds: $256 → $256 ($0)

Holders
1
Holders Change
–
Holders Change %
0%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
UCB
1
United Community Bank
South Carolina
$256 – – –

CMED Hedge Fund Activity: Q1 2022 in Review

1 of the 6,341 institutional investors tracked by Wall St. Rank reported a position in CHINA MEDICAL TECHNOLOGIES, INC SPN ADR (CMED) for Q1 2022, worth a combined $256 — unchanged from a quarter earlier.

Fund positioning in CMED was balanced in Q1 2022: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 0 trimmed.

  • 1 institutional investor held CHINA MEDICAL TECHNOLOGIES, INC SPN ADR (CMED) as of Q1 2022, unchanged from Q4 2021.
  • Funds reported $256 of CHINA MEDICAL TECHNOLOGIES, INC SPN ADR stock for Q1 2022, unchanged quarter-over-quarter.
  • 0 funds opened new CHINA MEDICAL TECHNOLOGIES, INC SPN ADR positions in Q1 2022 and 0 closed out.

Based on aggregated 13F filings for Q1 2022.